Telomir Pharmaceuticals Inc. Common Stock (TELO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Telomir Pharmaceuticals I...

    NASDAQ: TELO · Real-Time Price · USD
    1.18
    -0.02 (-1.67%)
    At close: Sep 03, 2025, 3:59 PM
    1.16
    -1.69%
    After-hours: Sep 03, 2025, 05:09 PM EDT

    Telomir Pharmaceuticals Common Stock Balance Sheet Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.27M 1.23K 1.42K n/a
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a 4.34M 47.31K n/a
    Receivables
    		 n/a 130K n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 57.87K 303.28K 47.31K n/a
    Total Current Assets
    		 1.32M 435.23K 48.73K n/a
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a 4.34M 47.31K n/a
    Total Assets
    		 1.32M 4.77M 48.73K n/a
    Account Payables
    		 587.54K 707.19K 404.22K 18.73K
    Deferred Revenue
    		 n/a n/a -581.79K -119.4K
    Short-Term Debt
    		 93.43K 101K 581.79K 119.4K
    Other Current Liabilities
    		 -93.43K 527.38K -581.79K -119.4K
    Total Current Liabilities
    		 680.97K 1.34M 986.01K 138.13K
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Liabilities
    		 680.97K 1.34M 986.01K 138.13K
    Total Debt
    		 93.43K 101K 581.79K 119.4K
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -30.6M -14.06M -992.28K -138.13K
    Comprehensive Income
    		 n/a n/a n/a -55K
    Shareholders Equity
    		 643.04K 3.44M -937.28K -138.13K
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist